Plasma membrane gp96 enhances invasion and metastatic potential of liver cancer via regulation of uPAR
Targeted therapy is currently under intensive investigation due to the resistance of liver cancer to cytotoxic chemotherapies. Dissecting the molecular events that drive the progression of liver cancer and defining specific targets are urgently needed to develop efficient tailored therapies. Cell me...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-08-01
|
| Series: | Molecular Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1016/j.molonc.2015.03.004 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850146893988888576 |
|---|---|
| author | Junwei Hou Xin Li Changfei Li Lu Sun Yulai Zhao Jingmin Zhao Songdong Meng |
| author_facet | Junwei Hou Xin Li Changfei Li Lu Sun Yulai Zhao Jingmin Zhao Songdong Meng |
| author_sort | Junwei Hou |
| collection | DOAJ |
| description | Targeted therapy is currently under intensive investigation due to the resistance of liver cancer to cytotoxic chemotherapies. Dissecting the molecular events that drive the progression of liver cancer and defining specific targets are urgently needed to develop efficient tailored therapies. Cell membrane gp96 (mgp96) has been implicated in tumor growth and malignancy. Here, we explored the functional and clinical relevance of mgp96 in liver cancer. We found that elevated mgp96 abundance was associated with tumor metastasis and recurrence in patients with primary liver tumors. Decreased KDELR1 levels in hepatoma cells contribute to cell membrane translocation of the normally ER‐resident gp96. Urokinase‐type plasminogen activator receptor (uPAR) was identified as a mgp96 client protein, and mgp96 stabilized uPAR protein. Our clinical results proved that elevated mgp96 abundance is positively correlated with uPAR expression levels in liver tumors. We further provided evidence that targeting mgp96 with siRNA or a specific mAb that blocked the mgp96‐uPAR interaction led to inhibited cell growth, survival, and invasion in vitro, as well as the suppression of liver tumor growth and metastasis in vivo. mgp96 promotes liver cancer progression through increasing the protein stability and signaling of uPAR, and may be a new promising target for suppressing uPAR‐mediated tumor growth and metastasis in liver cancer. |
| format | Article |
| id | doaj-art-e799a16b55a84017bf76cb98339d2dcc |
| institution | OA Journals |
| issn | 1574-7891 1878-0261 |
| language | English |
| publishDate | 2015-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | Molecular Oncology |
| spelling | doaj-art-e799a16b55a84017bf76cb98339d2dcc2025-08-20T02:27:43ZengWileyMolecular Oncology1574-78911878-02612015-08-01971312132310.1016/j.molonc.2015.03.004Plasma membrane gp96 enhances invasion and metastatic potential of liver cancer via regulation of uPARJunwei Hou0Xin Li1Changfei Li2Lu Sun3Yulai Zhao4Jingmin Zhao5Songdong Meng6CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, PR ChinaCAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, PR ChinaCAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, PR ChinaCAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, PR ChinaInstitute of Infectious Diseases, Beijing 302 Hospital, Beijing, PR ChinaInstitute of Infectious Diseases, Beijing 302 Hospital, Beijing, PR ChinaCAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, PR ChinaTargeted therapy is currently under intensive investigation due to the resistance of liver cancer to cytotoxic chemotherapies. Dissecting the molecular events that drive the progression of liver cancer and defining specific targets are urgently needed to develop efficient tailored therapies. Cell membrane gp96 (mgp96) has been implicated in tumor growth and malignancy. Here, we explored the functional and clinical relevance of mgp96 in liver cancer. We found that elevated mgp96 abundance was associated with tumor metastasis and recurrence in patients with primary liver tumors. Decreased KDELR1 levels in hepatoma cells contribute to cell membrane translocation of the normally ER‐resident gp96. Urokinase‐type plasminogen activator receptor (uPAR) was identified as a mgp96 client protein, and mgp96 stabilized uPAR protein. Our clinical results proved that elevated mgp96 abundance is positively correlated with uPAR expression levels in liver tumors. We further provided evidence that targeting mgp96 with siRNA or a specific mAb that blocked the mgp96‐uPAR interaction led to inhibited cell growth, survival, and invasion in vitro, as well as the suppression of liver tumor growth and metastasis in vivo. mgp96 promotes liver cancer progression through increasing the protein stability and signaling of uPAR, and may be a new promising target for suppressing uPAR‐mediated tumor growth and metastasis in liver cancer.https://doi.org/10.1016/j.molonc.2015.03.004mgp96uPARLiver cancerMAPKDFS |
| spellingShingle | Junwei Hou Xin Li Changfei Li Lu Sun Yulai Zhao Jingmin Zhao Songdong Meng Plasma membrane gp96 enhances invasion and metastatic potential of liver cancer via regulation of uPAR Molecular Oncology mgp96 uPAR Liver cancer MAPK DFS |
| title | Plasma membrane gp96 enhances invasion and metastatic potential of liver cancer via regulation of uPAR |
| title_full | Plasma membrane gp96 enhances invasion and metastatic potential of liver cancer via regulation of uPAR |
| title_fullStr | Plasma membrane gp96 enhances invasion and metastatic potential of liver cancer via regulation of uPAR |
| title_full_unstemmed | Plasma membrane gp96 enhances invasion and metastatic potential of liver cancer via regulation of uPAR |
| title_short | Plasma membrane gp96 enhances invasion and metastatic potential of liver cancer via regulation of uPAR |
| title_sort | plasma membrane gp96 enhances invasion and metastatic potential of liver cancer via regulation of upar |
| topic | mgp96 uPAR Liver cancer MAPK DFS |
| url | https://doi.org/10.1016/j.molonc.2015.03.004 |
| work_keys_str_mv | AT junweihou plasmamembranegp96enhancesinvasionandmetastaticpotentialoflivercancerviaregulationofupar AT xinli plasmamembranegp96enhancesinvasionandmetastaticpotentialoflivercancerviaregulationofupar AT changfeili plasmamembranegp96enhancesinvasionandmetastaticpotentialoflivercancerviaregulationofupar AT lusun plasmamembranegp96enhancesinvasionandmetastaticpotentialoflivercancerviaregulationofupar AT yulaizhao plasmamembranegp96enhancesinvasionandmetastaticpotentialoflivercancerviaregulationofupar AT jingminzhao plasmamembranegp96enhancesinvasionandmetastaticpotentialoflivercancerviaregulationofupar AT songdongmeng plasmamembranegp96enhancesinvasionandmetastaticpotentialoflivercancerviaregulationofupar |